© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
Long COVID Risk Declined Over the Pandemic and Vaccination was Key, But Risk Remains
July 18, 2024
Ziyad Al-Aly, MD, and colleagues link 70% of the drop in cases to vaccine availability but caution the risk for long COVID remains significant.
Immunotherapy to Delay, Treat Type 1 Diabetes Wins FDA Fast Track Designation
July 18, 2024
The antigen-specific immunotherapy preserves endogenous insulin production via intralymphatic injection of recombinant GAD65 protein, according to Diamyd Medical.
Weight Gain in Early Adult Life Linked to Adverse Cardiac Function, Structure in Older Age
July 17, 2024
Adiposity before age 60 to 64 years, beginning as early as age 20 years, was associated with adverse cardiac structure and function not explained by current BMI.
Roche Oral Incretin Mimetic CT-966 Moves to Phase 2 Clinical Development
July 17, 2024
The oral GLP-1 RA was associated with weight loss of 7.3% in just 4 weeks and is designed with unique properties that will enhance multiple outcomes, Roche said.
Rapid Rise in Rates of Diabetes During Pregnancy in Canada Not Expected to Slow
July 16, 2024
The most concerning escalation in type 1, type 2, and gestational diabetes has been among the youngest women and girls, aged 15 to 19 years, report study authors.
Lowering Daily Sodium Intake May Reduce AF Risk in Vulnerable Adults
July 16, 2024
An analysis of 28 000 adults with vascular disease and high-risk diabetes found daily sodium intake of ≥8 g significantly increased risk for AF by 32%.
Intranasal Flu Vaccine Coadministered with High-Dose Shot More Effective in Older Adults than Shot Alone
July 15, 2024
The investigational live intranasal vaccine was safe and well-tolerated when given concomitantly with Fluzone HD and the combination outperformed the latter given by itself.
GRAIL Multicancer Early Detection Test Registrational Trials Make Good Progress, Company Says
July 15, 2024
The PATHFINDER 2 and HMS-Galleri trials are proceeding as planned with more than 175 000 participants from diverse backgrounds enrolled across both.
Novel Combination Treatment is Potent Driver of Beta Cell Proliferation in Type 1 Diabetes Model
July 12, 2024
In the mouse model of type 1 diabetes, a combined harmine/exendin-4 therapy resulted in an up to 7-fold increase in β cell numbers over 3 months, reported investigators.
Combined SGLT2i and GLP-1 RA Therapy Provides Complementary Cardiorenal Protection, According to Comprehensive Meta-Analysis
July 12, 2024
Findings from the large meta-analysis provide strong support for use of both classes to reduce CV and renal disease in adults with type 2 diabetes.